Literature DB >> 21410460

Early potassium channel blockade improves sepsis-induced organ damage and cardiovascular dysfunction.

R Sordi1, D Fernandes, B T Heckert, J Assreuy.   

Abstract

BACKGROUND AND
PURPOSE: There is increasing evidence that potassium channels are involved in the cardiovascular dysfunction of sepsis. This evidence was obtained after the systemic inflammation, cardiovascular dysfunction and organ damage had developed. Here we have studied the consequences of early interference with potassium channels on development of sepsis. EXPERIMENTAL APPROACH: Sepsis was induced by caecal ligation and puncture (CLP) or sham surgery in Wistar rats. Four hours after surgery, animals received tetraethylammonium (TEA; a non-selective potassium channel blocker) or glibenclamide (a selective ATP-sensitive potassium channel blocker). Twenty-four hours after surgery, inflammatory, biochemical, haemodynamic parameters and survival were evaluated. KEY
RESULTS: Sepsis significantly increased plasma NO(x) levels, expression of inducible nitric oxide synthase (NOS-2) protein in lung and thigh skeletal muscle, lung myeloperoxidase, urea, creatinine and lactate levels, TNF-α and IL-1β, hypotension and hyporesponsiveness to phenylephrine and hyperglycemia followed by hypoglycemia. TEA injected 4 h after surgery attenuated the increased NOS-2 expression, reduced plasma NO(x) , lung myeloperoxidase activity, levels of TNF-α and IL-1β, urea, creatinine and lactate levels, prevented development of hypotension and hyporesponsiveness to phenylephrine, the alterations in plasma glucose and reduced late mortality by 50%. Glibenclamide did not improve any of the measured parameters and increased mortality rate, probably due to worsening the hypoglycemic phase of sepsis. CONCLUSIONS AND IMPLICATIONS: Early blockade of TEA-sensitive (but not the ATP-sensitive subtype) potassium channels reduced organ damage and mortality in experimental sepsis. This beneficial effect seems to be, at least in part, due to reduction in NOS-2 expression.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21410460      PMCID: PMC3144541          DOI: 10.1111/j.1476-5381.2011.01324.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

1.  Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide.

Authors:  S M Gardiner; P A Kemp; J E March; T Bennett
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Role of nitric oxide in the failure of neutrophil migration in sepsis.

Authors:  C F Benjamim; S H Ferreira; F Q Cunha
Journal:  J Infect Dis       Date:  2000-06-29       Impact factor: 5.226

3.  Differential involvement of potassium channel subtypes in early and late sepsis-induced hyporesponsiveness to vasoconstrictors.

Authors:  Regina Sordi; Daniel Fernandes; Jamil Assreuy
Journal:  J Cardiovasc Pharmacol       Date:  2010-08       Impact factor: 3.105

4.  Hydrogen sulfide improves neutrophil migration and survival in sepsis via K+ATP channel activation.

Authors:  Fernando Spiller; Maria I L Orrico; Daniele C Nascimento; Paula G Czaikoski; Fabrício O Souto; José C Alves-Filho; Andressa Freitas; Daniela Carlos; Marcelo F Montenegro; Alberto F Neto; Sergio H Ferreira; Marcos A Rossi; John S Hothersall; Jamil Assreuy; Fernando Q Cunha
Journal:  Am J Respir Crit Care Med       Date:  2010-03-25       Impact factor: 21.405

5.  Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.

Authors:  S L Archer; J M Huang; V Hampl; D P Nelson; P J Shultz; E K Weir
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

6.  Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis.

Authors:  S R Maitra; M M Wojnar; C H Lang
Journal:  Shock       Date:  2000-05       Impact factor: 3.454

7.  Essential role of CCR2 in neutrophil tissue infiltration and multiple organ dysfunction in sepsis.

Authors:  Fabricio O Souto; José C Alves-Filho; Walter M Turato; Maria Auxiliadora-Martins; Aníbal Basile-Filho; Fernando Q Cunha
Journal:  Am J Respir Crit Care Med       Date:  2010-08-23       Impact factor: 21.405

8.  Differential involvement of guanylate cyclase and potassium channels in nitric oxide-induced hyporesponsiveness to phenylephrine in endotoxemic rats.

Authors:  José Eduardo da Silva-Santos; Marcia Ribeiro Terluk; Jamil Assreuy
Journal:  Shock       Date:  2002-01       Impact factor: 3.454

9.  Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.

Authors:  Angel López; Jose Angel Lorente; Jay Steingrub; Jan Bakker; Angela McLuckie; Sheila Willatts; Michael Brockway; Antonio Anzueto; Laurent Holzapfel; Desmond Breen; Michael S Silverman; Jukka Takala; Jill Donaldson; Carl Arneson; Geraldine Grove; Steven Grossman; Robert Grover
Journal:  Crit Care Med       Date:  2004-01       Impact factor: 7.598

Review 10.  Insulin therapy for the critically ill patient.

Authors:  Greet Van den Berghe
Journal:  Clin Cornerstone       Date:  2003
View more
  11 in total

Review 1.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

2.  Inhibition of IκB Kinase Attenuates the Organ Injury and Dysfunction Associated with Hemorrhagic Shock.

Authors:  Regina Sordi; Fausto Chiazza; Florence L Johnson; Nimesh S A Patel; Karim Brohi; Massimo Collino; Christoph Thiemermann
Journal:  Mol Med       Date:  2015-06-18       Impact factor: 6.354

3.  Glucose homeostasis in two degrees of sepsis lethality induced by caecum ligation and puncture in mice.

Authors:  Francielle B D Ferreira; Cristiane Dos Santos; Maciel A Bruxel; Everson A Nunes; Fernando Spiller; Alex Rafacho
Journal:  Int J Exp Pathol       Date:  2017-12-11       Impact factor: 1.925

4.  Anti-nociceptive and anti-edematogenic effects of glibenclamide in a model of acute gouty attack in rats.

Authors:  Rosane M S dos Santos; Sara M Oliveira; Cássia R Silva; Carin Hoffmeister; Juliano Ferreira; Jamil Assreuy
Journal:  Inflamm Res       Date:  2013-03-30       Impact factor: 4.575

5.  GTS-21 Protected Against LPS-Induced Sepsis Myocardial Injury in Mice Through α7nAChR.

Authors:  Weilan Kong; Kai Kang; Yang Gao; Haitao Liu; Xianglin Meng; Yanhui Cao; Songliu Yang; Wen Liu; Jiannan Zhang; Kaijiang Yu; Mingyan Zhao
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

6.  Deletion of Nlrp3 Augments Survival during Polymicrobial Sepsis by Decreasing Autophagy and Enhancing Phagocytosis.

Authors:  Liliang Jin; Sanjay Batra; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2016-12-28       Impact factor: 5.422

7.  The role of nitric oxide in sepsis-associated kidney injury.

Authors:  Filipe Rodolfo Moreira Borges Oliveira; Jamil Assreuy; Regina Sordi
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

8.  Pneumonia-induced sepsis in mice: temporal study of inflammatory and cardiovascular parameters.

Authors:  Regina Sordi; Octávio Menezes-de-Lima; Ana M Della-Justina; Edir Rezende; Jamil Assreuy
Journal:  Int J Exp Pathol       Date:  2013-02-27       Impact factor: 1.925

9.  Fluid resuscitation therapy in endotoxemic hamsters improves survival and attenuates capillary perfusion deficits and inflammatory responses by a mechanism related to nitric oxide.

Authors:  Nivaldo Ribeiro Villela; Ana Olimpia Maia Teixeira dos Santos; Marcos Lopes de Miranda; Eliete Bouskela
Journal:  J Transl Med       Date:  2014-08-24       Impact factor: 5.531

Review 10.  A Protective Role of Glibenclamide in Inflammation-Associated Injury.

Authors:  Gensheng Zhang; Xiuhui Lin; Shufang Zhang; Huiqing Xiu; Chuli Pan; Wei Cui
Journal:  Mediators Inflamm       Date:  2017-06-27       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.